enGene names Michael Heffernan board chairman as Richard Glickman steps down - ENGN News | RalliesenGene names Michael Heffernan board chairman as Richard Glickman steps down
E
ENGN• Board chairman change at enGene
- enGene named Michael Heffernan chairman, replacing Dr. Richard Glickman, who is stepping down after more than 14 years in the role.
- Heffernan joined the board in July 2025; he founded Collegium Pharmaceutical, serving as president, CEO, chairman.
- Board shift aligns with planned pre-BLA FDA meeting in 2H 2026, targeted BLA start in 2H 2026, potential 2027 approval.
ELF
•
